Publications by Year: 2018

2018

Deal, Jennifer A, Adele M Goman, Marilyn S Albert, Michelle L Arnold, Sheila Burgard, Theresa Chisolm, David Couper, et al. (2018) 2018. “Hearing Treatment for Reducing Cognitive Decline: Design and Methods of the Aging and Cognitive Health Evaluation in Elders Randomized Controlled Trial.”. Alzheimer’s & Dementia (New York, N. Y.) 4: 499-507. https://doi.org/10.1016/j.trci.2018.08.007.

INTRODUCTION: Hearing impairment is highly prevalent and independently associated with cognitive decline. The Aging and Cognitive Health Evaluation in Elders study is a multicenter randomized controlled trial to determine efficacy of hearing treatment in reducing cognitive decline in older adults. Clinicaltrials.gov Identifier: NCT03243422.

METHODS: Eight hundred fifty participants without dementia aged 70 to 84 years with mild-to-moderate hearing impairment recruited from four United States field sites and randomized 1:1 to a best-practices hearing intervention or health education control. Primary study outcome is 3-year change in global cognitive function. Secondary outcomes include domain-specific cognitive decline, incident dementia, brain structural changes on magnetic resonance imaging, health-related quality of life, physical and social function, and physical activity.

RESULTS: Trial enrollment began January 4, 2018 and is ongoing.

DISCUSSION: When completed in 2022, Aging and Cognitive Health Evaluation in Elders study should provide definitive evidence of the effect of hearing treatment versus education control on cognitive decline in community-dwelling older adults with mild-to-moderate hearing impairment.

Sanchez, Victoria A, Deborah A Hall, Bonnie Millar, Celia D Escabi, Alice Sharman, Jeannette Watson, Sornaraja Thasma, and Peter Harris. (2018) 2018. “Recruiting ENT and Audiology Patients into Pharmaceutical Trials: Evaluating the Multi-Centre Experience in the UK and USA.”. International Journal of Audiology 57 (sup4): S55-S66. https://doi.org/10.1080/14992027.2018.1425002.

OBJECTIVE: Recruiting into clinical trials on time and on target is a major challenge and yet often goes unreported. This study evaluated the adjustment to procedures, recruitment and screening methods in two multi-centre pharmaceutical randomised controlled trials (RCTs) for hearing-related problems in adults.

DESIGN: Recruitment monitoring and subsequent adjustment of various study procedures (e.g. eligibility criteria, increasing recruiting sites and recruitment methods) are reported. Participants were recruited through eight overarching methods: trial registration, posters/flyers, print publications, Internet, social media, radio, databases and referrals. The efficiency of the recruitment was measured by determining the number of people: (1) eligible for screening as a percentage of those who underwent telephone pre-screening and (2) randomised as a percentage of those screened.

STUDY SAMPLE: A total of 584 participants completed the pre-screening steps, 491 screened and 169 participants were randomised.

RESULTS: Both RCTs completed adjustments to the participant eligibility, added new study sites and additional recruitment methods. No single recruitment method was efficient enough to serve as the only route to enrolment.

CONCLUSION: A diverse portfolio of methods, continuous monitoring, mitigation strategy and adequate resourcing were essential for achieving our recruitment goals.